- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Jun 25, 2019 at 02:59:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Jun 26, 2019 | T-1288-18 | MSJ | Gemak Trust V. Jempak Corporation Et Al (Patent) | Toronto | 2 d |
| Jun 26, 2019 | T-1790-17 | CMC | Valley Blades Ltd. V. Usinage Pro-24 Inc. C/o/b As Nordik Blades (Patent) | Ottawa | 1 h |
| Jun 26, 2019 | T-1963-18 | JR | Robert Forget C. Charm Jewelry Limited (Trade Mark - JR) | Québec | 1 d |
| Jun 26, 2019 | T-396-13 | M | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 2.5 h |
| Jun 26, 2019 | T-416-19 | CMC | Usinage Pro-24 Inc. V. Valley Blades Ltd. (Patent) | Ottawa | 1 h |
| Jun 26, 2019 | T-533-16 | CMC | Fgf Brands, Inc. V. Twi Foods Inc. (Patent) | Toronto | 30 m |
| Jun 26, 2019 | T-66-12 | CMC | Fgf Brands, Inc. V. Twi Foods Inc. (Patent) | Toronto | 30 m |
| Jun 26, 2019 | T-704-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 1 h |
| Jun 26, 2019 | T-705-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 1 h |
| Jun 26, 2019 | T-706-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - PIRFENIDONE*) | Toronto | 1 h |
| Jun 26, 2019 | T-708-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 1 h |
| Jun 26, 2019 | T-768-19 | CMC | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 1 h |
| Jun 26, 2019 | T-770-19 | CMC | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 1 h |
| Jun 26, 2019 | T-896-19 | CMC | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 1 h |
| Jun 26, 2019 | T-897-19 | CMC | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 1 h |
| Jun 26, 2019 | T-898-19 | CMC | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 1 h |
| Jun 26, 2019 | T-899-19 | CMC | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 1 h |
| Jun 27, 2019 | T-783-17 | MED | Palos Verdes Building Corp. V. Tced Intl Inc. (Trade Mark) | Montréal | 1 d |
| Jun 27, 2019 | A-178-19 | APP | Apotex Inc. V Bristol-myers Squibb Canada Co. Et Al (Patent - Apixaban*) | Toronto | 2 h |
| Jun 27, 2019 | T-1425-18 | M | Tracbeam, Llc V. Bell Mobility Inc. Et Al (Patent) | Toronto | 1 d |
| Jun 27, 2019 | T-1004-18 | CMC | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 30 m |
| Jun 27, 2019 | T-1049-18 | CMC | Re/max, Llc V. Save Max Real Estate, Inc. Et Al. (Trade Mark) | Vancouver | 1 h |
| Jun 27, 2019 | T-191-18 | CMC | United American Corp And Investal Capital Corporation V. Facebook Canada Ltd (Patent) | Vancouver | 1 h |
| Jun 27, 2019 | T-205-18 | CMC | United American Corp And Investal Capital Corporation V. Instagram, Inc (Patent) | Vancouver | 1 h |
| Jun 28, 2019 | T-759-16 | CH | Bell Canada Et Al V. Watchnsavenow Inc. Et Al (Copyright) | Toronto | 1 d |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Sep 3, 2019 | T-2046-12 | Rogers Communications Partnership Et Al And Society Of Composers Et Al (Copyright) | Toronto | 5 d |
| Sep 12, 2019 | T-2046-12 | Rogers Communications Partnership Et Al And Society Of Composers Et Al (Copyright) | Toronto | 2 d |
| Sep 16, 2019 | T-633-18 | Nutramax Laboratories, Inc. V. Aventix Animal Health Corporation (Patent) | Ottawa | 5 d |
| Sep 18, 2019 | T-1321-97 | Eli Lilly And Co. Et Al V. Apotex Inc. (Patent - Cefaclor*) | Toronto | 2 d |
| Sep 30, 2019 | T-353-18 | Janssen Inc. Et Al V. Teva Canada Limited (Patent - Paliperidone*) | Toronto | 10 d |
| Oct 21, 2019 | T-783-17 | Palos Verdes Building Corp. V. Tced Intl Inc. (Trade Mark) | Montréal | 10 d |
| Oct 21, 2019 | T-598-15 | Specialized Desanders Inc. V. Enercorp Sand Solution Inc. Et Al. (Patent) | Calgary | 15 d |
| Oct 21, 2019 | T-608-17 | Seedlings Life Science Ventures,llc V. Pfizer Canada Inc. (Patent) | Ottawa | 15 d |
| Nov 4, 2019 | T-350-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Nov 4, 2019 | T-351-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Nov 18, 2019 | T-301-16 | Wi-lan Inc. V. Telus Corporation Et Al. (Patent) | Toronto | 15 d |
| Nov 18, 2019 | T-303-16 | Wi-lan Inc. V. Bell Mobility Inc. (Patent) | Toronto | 15 d |
| Nov 18, 2019 | T-304-16 | Wi-lan Inc. V. Rogers Communications Canada Inc. (Patent) | Toronto | 15 d |
| Nov 25, 2019 | T-1151-17 | Molson Canada 2005 V. Labatt Brewing Company Limited/la Brasserie Labatt (Trade Mark) | Toronto | 10 d |
| Nov 25, 2019 | T-377-16 | Biofert Manufacturing Inc. V. Agrisol Manufacturing Inc. And Others (Trade Mark) | Vancouver | 14 d |
| Dec 2, 2019 | T-896-15 | Georgetown Rail Equipment Company V. Rail Radar Inc. Et Al (Patent) | Toronto | 5 d |
| Dec 2, 2019 | T-1623-16 | Eli Lilly Canada Inc. Et Al V. Pharmascience Inc. (Patent - Tadalafil*) | Ottawa | 15 d |
| Dec 2, 2019 | T-1627-16 | Eli Lilly Canada Inc. Et Al. V. Mylan Pharmaceuticals Ulc (Patent - Tadalafil*) | Ottawa | 15 d |
| Dec 2, 2019 | T-1631-16 | Eli Lilly Canada Inc. Et Al. V. Teva Canada Limited (Patent - Tadalafil*) | Ottawa | 15 d |
| Dec 2, 2019 | T-1632-16 | Eli Lilly Canada Inc., Eli Lilly And Company Et Al. V. Apotex Inc. (Patent - Tadalafil*) | Ottawa | 15 d |
| Dec 9, 2019 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Winnipeg | 10 d |
| Jan 6, 2020 | T-1471-17 | Pfizer Canada Inc. V. Genentech, Inc. Et Al (Patent - Bevacizumab*) | Toronto | 10 d |
| Jan 13, 2020 | T-1632-16 | Eli Lilly Canada Inc., Eli Lilly And Company Et Al. V. Apotex Inc. (Patent - Tadalafil*) | Ottawa | 5 d |
| Jan 20, 2020 | T-741-18 | Amgen Inc. Et Al V. Pfizer Canada Ulc (Patent - Pegfilgrastim*) | Toronto | 10 d |
| Jan 20, 2020 | T-1627-16 | Eli Lilly Canada Inc. Et Al. V. Mylan Pharmaceuticals Ulc (Patent - Tadalafil*) | Ottawa | 5 d |
| Jan 27, 2020 | T-1623-16 | Eli Lilly Canada Inc. Et Al V. Pharmascience Inc. (Patent - Tadalafil*) | Ottawa | 5 d |
| Jan 27, 2020 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 15 d |
| Feb 3, 2020 | T-1631-16 | Eli Lilly Canada Inc. Et Al. V. Teva Canada Limited (Patent - Tadalafil*) | Ottawa | 5 d |
| Feb 3, 2020 | T-546-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Et Al (Patent) | Montréal | 23 d |
| Feb 17, 2020 | T-2004-13 | Sanofi Et Al V. Sandoz Canada Inc. (Patent - Clopidogrel*) | Toronto | 12 d |
| Feb 17, 2020 | T-2009-13 | Sanofi Et Al V. Pharmascience Inc. Et Al (Patent - Clopidogrel*) | Toronto | 12 d |
| Feb 24, 2020 | T-229-18 | Varco I/p Et Al V. Coil Solutions, Inc. (Patent) | Toronto | 14 d |
| Mar 2, 2020 | T-1349-17 | Wi-lan, Inc. V. Lg Electronics, Inc. Et Al (Patent) | Toronto | 15 d |
| Mar 2, 2020 | T-1163-18 | Biogen Canada Inc Et Al V. Taro Pharmaceuticals Inc (Patent - Fampridine*) | Toronto | 10 d |
| Mar 2, 2020 | T-1416-18 | Biogen Canada Inc. And Others V. Apotex Inc. (Patent - Fampridine*) | Toronto | 10 d |
| Mar 2, 2020 | T-220-19 | Biogen Canada Inc. Et Al. V. Pharmascience Inc. (Patent - Fampridine*) | Toronto | 10 d |
| Mar 9, 2020 | T-921-17 | Rovi Guides, Inc. Et Al V. Videotron G.p. Et Al (Patent) | Toronto | 20 d |
| Mar 30, 2020 | T-1527-18 | Celgene Inc.et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| Mar 30, 2020 | T-1529-18 | Celgene Inc. Et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| Apr 20, 2020 | T-1069-14 | Jason Swist Et Al V. Meg Energy Corp. (Patent) | Toronto | 10 d |
| Apr 20, 2020 | T-1416-18 | Biogen Canada Inc. And Others V. Apotex Inc. (Patent - Fampridine*) | Toronto | 5 d |
| Apr 20, 2020 | T-1503-18 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Filgrastim*) | Toronto | 10 d |
| May 4, 2020 | T-569-17 | J.r. Simplot Company V. Mccain Foods Ltd. V. Simplot Canada (ii) Limited (Trade Mark) | Ottawa | 7 d |
| May 4, 2020 | T-1711-16 | Houghton International Inc Et Al V. Nts-northern Technical Solutions Inc (Patent) | Toronto | 7 d |
| May 4, 2020 | T-1974-18 | Celgene Inc. Et Al V. Apotex Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| May 4, 2020 | T-1975-18 | Celgene Inc. Et Al V. Apotex Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| May 4, 2020 | T-1976-18 | Celgene Inc. Et Al V. Apotex Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| May 4, 2020 | T-1977-18 | Celgene Inc. Et Al V. Apotex Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| May 11, 2020 | T-311-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Dba Reebok-ccm Hockey (Trade Mark) | Montréal | 13 d |
| May 25, 2020 | T-113-18 | Rovi Guides Inc Et Al V. Bce Inc. Et Al (Patent) | Toronto | 20 d |
| May 25, 2020 | T-206-18 | Rovi Guides, Inc. Et Al V. Telus Corporation Et Al (Patent) | Toronto | 20 d |
| Jun 8, 2020 | T-1692-18 | Cubist Pharmaceuticals Llc Et Al V. Teva Canada Limited (Patent - Daptomycin*) | Toronto | 10 d |
| Jun 15, 2020 | T-2023-18 | Allergan Inc. V. Sandoz Canada Inc. Et Al (Patent - Silodosin*) | Toronto | 10 d |
| Jul 15, 2020 | T-220-19 | Biogen Canada Inc. Et Al. V. Pharmascience Inc. (Patent - Fampridine*) | Ottawa | 3 d |
| Aug 24, 2020 | T-2182-18 | Teva Canada Innovation Et Al. V. Pharmascience Et Al. (Patent - Glatiramer*) | Toronto | 10 d |
| Aug 24, 2020 | T-2183-18 | Teva Canada Innovation And Others V. Pharmascience Inc. And Others (Patent - Glatiramer*) | Toronto | 10 d |
| Aug 31, 2020 | T-913-17 | Canadian National Railway Company V. Bnsf Railway Company Et Al. (Patent) | Toronto | 14 d |
| Sep 14, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Ottawa | 10 d |
| Sep 14, 2020 | T-1989-18 | Astrazeneca Canada Inc Et Al V. Taro Pharmaceuticals Inc. (Patent - Ticagrelor*) | Toronto | 7 d |
| Sep 14, 2020 | T-97-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-98-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-99-19 | Bristol-myers Squibb Canada Co. Et Al V. Natco Pharma (canada) Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-503-19 | Bristol-myers Squibb Canada Co. Et Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-504-19 | Bristol-myers Squibb Canada Co. El Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Oct 13, 2020 | T-954-18 | Deeproot Green Infrastructure, Llc Et Al V. Greenblue Urban North America In (Patent) | Toronto | 13 d |
| Oct 19, 2020 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Oct 26, 2020 | T-84-19 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-181-19 | Janssen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-182-19 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Nov 16, 2020 | T-630-18 | Maoz Betser-zilevitch V. Canadian Natural Resources Ltd. (Patent) | Toronto | 10 d |
| Nov 30, 2020 | T-1184-17 | Merck Sharp & Dohme Corp.et Al V. Wyeth Llc (Patent - Pneumococcal*) | Toronto | 10 d |
| Dec 7, 2020 | T-518-19 | Cubist Pharmaceuticals Llc Et Al V. Sandoz Canada Inc. (Patent - Daptomycin*) | Toronto | 10 d |
| Jan 11, 2021 | T-704-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-705-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-706-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - PIRFENIDONE*) | Toronto | 10 d |
| Jan 11, 2021 | T-708-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 18, 2021 | T-151-16 | Angelcare Development Inc. Et Al. V. Munchkin, Inc Et Al. (Patent) | Montréal | 40 d |
| Jan 25, 2021 | T-778-19 | Bayer Inc. Et Al. V .teva Canada Ltd. (Patent - Sorafenib*) | Toronto | 12 d |
| Feb 1, 2021 | T-794-19 | Allergan Inc. Et Al V. Apotex Inc. (Patent - Risedronate*) | Toronto | 10 d |
| Feb 8, 2021 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Feb 8, 2021 | T-1133-18 | Merck Sharp & Dohme Corp. Et Al V. Glaxosmithkline Biologicals S.a. (Patent) | Toronto | 15 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Jun 26, 2019 | T-1963-18 | Robert Forget C. Charm Jewelry Limited | Trade Mark Expungement | Québec | 1 d |
| Jul 8, 2019 | T-562-18 | Isaac Bennet Sales Agencies Inc. V. Arcadia Group Brands Limited | Trade Mark Opposition | Toronto | 1 d |
| Jul 16, 2019 | T-1866-18 | The Winning Combination Inc. V. Canada (minister Of Health) Et Al | S. 18.1 Application for Judicial Review | Winnipeg | 1 d |
| Dec 5, 2019 | T-1629-17 | Wildchild Stockholm, Inc. V. Minister Of Health Et Al | S. 18.1 Application for Judicial Review | Toronto | 2 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Jun 27, 2019 | A-178-19 | Apotex Inc. V Bristol-myers Squibb Canada Co. Et Al - Apixaban* | Appeal (S.27 - Interloc.) - Patent Act | Toronto | 2 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.